Analysis of survival adjusted for quality of life using the Q-TWiST function: Interface in R

被引:9
作者
Bogart, Emilie [1 ,2 ]
Jouin, Anais [1 ,2 ]
Behal, Helene [2 ,3 ]
Duhamel, Alain [2 ,3 ]
Filleron, Thomas [4 ]
Kramar, Andrew [1 ,2 ]
机构
[1] Ctr Oscar Lambret, Methodol & Biostat Unit, 3 Rue Frederic Combemale, F-59020 Lille, France
[2] SIRIC ONCOLiIIe, Lille, France
[3] Uniu Lille Nord France, CHRU Lille, UDSL2, Methodol & Biostat Unit,EA2694, Lille, France
[4] Inst Claudius Regaud, IUCT O, Bur Essais Clin, Cellule Biostat, F-31059 Toulouse, France
关键词
Quality of life; Survival; Q-TWiST; R environment; CELL LUNG-CANCER; PHASE-III TRIAL; TIME; CHEMOTHERAPY; SYMPTOMS; PREVALENCE; CARCINOMA; THERAPY;
D O I
10.1016/j.cmpb.2015.11.005
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Objective: The analysis of treatment effects in clinical trials usually focus on efficacy and safety in separate descriptive statistical analyses. The Q-TWiST (Quality adjusted Time Without Symptoms and Toxicity) method has been proposed by Gelber in the 90s to enable a statistical comparison between two groups with a graphical representation by incorporating benefit and risk into a single analysis. Although the method has been programmed in SAS, it is rarely used. The availability of the method in the freely software environment system like R would greatly enhanced the accessibility by researchers. The objective of this paper is to present a program for Q-TWiST analyses within R software environment. Methods: The gtwist function was developed in order to estimate and compare Q-TWiST for two groups. Two individual patient data files are required used for input: one for visits and one for follow-up. Q-TWiST is obtained as a sum of time spent in three health states: period in toxicity (TOX), period without relapse and toxicity (TWiST) and period in relapse (REL), weighted by associated utility scores restricted to median overall survival for example. The bootstrap method is used for testing statistical significance. Threshold analysis and gain functions allow a group comparison for different utility values. Results: Input data is checked for consistency. Descriptive statistics and mean durations for each health state are provided, allowing statistical comparisons. Graphical results are presented in a PDF file. The use of the function is illustrated with data from a simulated data set and a randomized clinical trial. Conclusions: gtwist is an easy to use R function, allowing a quality adjusted survival analysis with the Q-TWiST method. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 22 条
[1]   Assessment of health status over time by Prevalence and Weighted Prevalence functions: Interface in R [J].
Cabarrou, B. ;
Jouin, A. ;
Boher, J. M. ;
Kramar, A. ;
Filleron, T. .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2015, 118 (03) :298-308
[2]   Quality-of-life - adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group Study [J].
Cole, BF ;
Gelber, RD ;
Kirkwood, JM ;
Goldhirsch, A ;
Barylak, E ;
Borden, E .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2666-2673
[3]   A QUALITY-OF-LIFE-ORIENTED ENDPOINT FOR COMPARING THERAPIES [J].
GELBER, RD ;
GELMAN, RS ;
GOLDHIRSCH, A .
BIOMETRICS, 1989, 45 (03) :781-795
[4]   A quality-adjusted time without symptoms or toxicity (Q-TWIST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer [J].
Gelber, RD ;
Goldhirsch, A ;
Cole, BF ;
Wieand, HS ;
Schroeder, G ;
Krook, JE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (15) :1039-1045
[5]  
Gelber S., 1988, QUALITY LIFE ASSESSM
[6]   QUALITY ADJUSTED SURVIVAL ANALYSIS [J].
GLASZIOU, PP ;
SIMES, RJ ;
GELBER, RD .
STATISTICS IN MEDICINE, 1990, 9 (11) :1259-1276
[7]   COSTS AND BENEFITS OF ADJUVANT THERAPY IN BREAST-CANCER - A QUALITY-ADJUSTED SURVIVAL ANALYSIS [J].
GOLDHIRSCH, A ;
GELBER, RD ;
SIMES, RJ ;
GLASZIOU, P ;
COATES, AS .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :36-44
[8]   Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial [J].
Jang, Raymond W. ;
Le Maitre, Aurelie ;
Ding, Keyue ;
Winton, Tim ;
Bezjak, Andrea ;
Seymour, Lesley ;
Shepherd, Frances A. ;
Leighl, Natasha B. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4268-4273
[9]  
Kramar A., 2002, OXFORD TXB ONCOLOGY
[10]   PHASE-III TRIAL COMPARING 2 LOW-DOSE RATES IN BRACHYTHERAPY OF CERVIX CARCINOMA - REPORT AT 2 YEARS [J].
LAMBIN, P ;
GERBAULET, A ;
KRAMAR, A ;
SCALLIET, P ;
HAIEMEDER, C ;
MALAISE, EP ;
CHASSAGNE, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 25 (03) :405-412